MediWound MDWD
NASDAQ MDWD
$13.73 -0.11 (-0.79%)
As of: Sep 10, 2026 · 3:59 PM EDT

MediWound (MDWD) Retained Earnings (2013 - 2026)

MediWound (MDWD) posted Retained Earnings of -$239.3 million for Q2 2026, down 4.52% on a QoQ basis from -$228.9 million in Q4 2025, and down 9.21% year-over-year from -$263.5 million in Q2 2025.

Analysis

MediWound (MDWD) Retained Earnings (2013 - 2026) Analysis & Trends

MediWound has reported Retained Earnings for 14 years, with the latest figure at -$239.3 million in Q2 2026.

  • On a quarterly basis, Retained Earnings fell 9.21% year-over-year to -$239.3 million in Q2 2026; TTM through Jun 2026 was -$239.3 million, a 9.21% decrease from a year earlier, with the FY2025 full-year figure at -$228.9 million, down 11.65% from the prior year.
  • Retained Earnings was -$239.3 million for Q2 2026 at MediWound, down from -$228.9 million in the prior quarter.
  • The five-year high for Retained Earnings was -$152.1 million in Q1 2022, with the low at -$239.3 million in Q2 2026.
  • Average Retained Earnings over 5 years is -$187.8 million, with a median of -$174.8 million recorded in 2023.
  • The sharpest annual moves came in 2023 and 2024: Retained Earnings decreased 4.0% in 2023, then dropped 17.29% in 2024.
  • Over 5 years, Retained Earnings stood at -$168.1 million in 2022, then retreated by 4.0% to -$174.8 million in 2023, then fell by 17.29% to -$205.0 million in 2024, then slipped by 11.65% to -$228.9 million in 2025, then declined by 4.52% to -$239.3 million in 2026.
  • The last three Retained Earnings figures came in at -$239.3 million (Q2 2026), -$228.9 million (Q4 2025), and -$219.1 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -22.28 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 9.53 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 15.69 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 37.62 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 558.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 5.10 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -6.33 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 20.97 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 5.13 Bn
10 MediWound 156.09 Mn 120.75 Mn 337,000.00 -239.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -239.27 Mn
Dec 31, 2025 -228.93 Mn
Jun 30, 2025 -219.09 Mn
Dec 31, 2024 -205.05 Mn
Jun 30, 2024 -190.86 Mn
Dec 31, 2023 -174.82 Mn
Jun 30, 2023 -170.88 Mn
Dec 31, 2022 -168.11 Mn
Sep 30, 2022 -160.65 Mn
Jun 30, 2022 -156.45 Mn
Mar 31, 2022 -152.10 Mn
Dec 31, 2021 -148.51 Mn
Sep 30, 2021 -144.35 Mn
Jun 30, 2021 -141.00 Mn
Mar 31, 2021 -137.81 Mn
Dec 31, 2020 -134.96 Mn
Sep 30, 2020 -133.22 Mn
Jun 30, 2020 -131.32 Mn
Mar 31, 2020 -128.22 Mn
Dec 31, 2019 -125.76 Mn